Members from the Qatari commercial attache’s office met with Gov. Eric Holcomb, Secretary of Commerce Brad Chambers and more than 30 Indiana-based companies on Tuesday.
Shares of Indianapolis-based Eli Lilly and Co., which makes an antibody treatment for COVID-19 that requires infusions, were down 2.7% in late-morning trading Friday, to $263.76 each.
A new report, released Tuesday, says major gaps in education and employment affect the lives of Black Indianapolis residents long-term, but businesses could help improve the situation.
City Nail Bar could open on South East Street, where recent commercial launches include an ice cream shop, a chiropractic office, a makeup and skincare salon and a massage therapy studio.
We urge thoughtful consideration of an Indiana legislative proposal to restrict how companies, schools and universities can impose vaccine and testing requirements.
Junior Achievement’s Central Indiana Business Hall of Fame is an opportunity to share the successes of great leaders in the central Indiana area with students as they begin to find their career path.
Curators cleared all of the artifacts from the Col. Eli Lilly Civil War Museum in 2018 after a leak in the Soldiers and Sailors Monument’s basement endangered the collection.
The biggest policy change—a system for Medicare to negotiate prices for prescription drugs—won’t begin to deliver lower costs until 2025, and then only for a selected set of 10 medicines, as well as insulin products.
Courtney Roberts previously spent 14 years with Eli Lilly and Co., most recently as the director of social impact for the company’s global health philanthropic partnerships.
People who could benefit from the antibody drug include cancer patients, organ transplant recipients and people taking immune-suppressing drugs for conditions like rheumatoid arthritis.
For the past year, Indiana employers have faced the challenge of whether to enforce COVID-19 vaccination mandates on workers who say the vaccines violate their religious beliefs.
Indianapolis-based Eli Lilly and Co. has inked a research collaboration and licensing agreement with Regor Therapeutics Group that could be worth up to $1.5 billion.
Indianapolis tourism officials say the city’s convention and events business should be almost fully recovered by the end of 2022—at least based on projections for attendance and economic impact.
Eli Lilly’s blockbuster drug for osteoporosis, Forteo, could face generic competition from Indian drugmaker Sun Pharmaceuticals if the company can get a federal judge to declare that a Lilly patent won’t be infringed.
